Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jordana Schmier"'
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Understanding the economic value of deucravacitinib and apremilast could assist treatment decision-making for patients with moderate to severe plaque psoriasis.Objective This study compared the cost per response (CPR) for US patients initi
Externí odkaz:
https://doaj.org/article/f02293324a8649d49be744bac27d627a
Autor:
Michael Girardi, Kacie Carlson, Xingyue Huang, Shelby L. Corman, Patrick Edmundson, Jordana Schmier, Hrishikesh P. Kale, Rutika Raina, Francine Foss
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Response rates of approved systemic therapies for cutaneous T-cell lymphoma (CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment patterns and response rates of extracorporeal photopheresis (ECP) in CTCL p
Externí odkaz:
https://doaj.org/article/b3cd79d46cd3458c9ee543bcfefa74d0
Autor:
Lei Si, Francesca Fiorentino, Mickael Hiligsmann, Bart Depreitere, Kevin Ong, Silvia Evers, Carmen Dirksen, Sem M M Hermans, Henk van Santbrink, Wouter L W van Hemert, Ruud Droeghaag, Valérie N E Schuermans, Anouk Y J M Smeets, Inge J M H Caelers, Sukhvinder Kalsi-Ryan, Anne Broekema, Axel Svedbom, Carmen Selva Sevilla, Daniel Cher, Henkvan Santbrink, Jordana Schmier, Jos Kuijlen, Laura De La Torre Perrez, Marieke Krol, Takahito Fujimori, Wouter van Hemert, Elske Vanden Akker–Van Marle
Publikováno v:
BMJ Open, Vol 13, Iss 7 (2023)
Objectives Despite the availability of general and national guidelines for the conduct and reporting of economic evaluations, there is heterogeneity in economic evolutions concerning spine surgery. This is partly the result of differing levels of adh
Externí odkaz:
https://doaj.org/article/630766e9d88948478dadc8ae0b788adf
Publikováno v:
Clinical Ophthalmology. 16:1055-1067
Deepinder K Dhaliwal,1 Viktor Chirikov,2 Jordana Schmier,2 Sanika Rege,2 Schalon Newton3 1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 2OPEN Health Evidence & Access, Bethesda, MD, USA; 3Trefoil Thera
Autor:
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Pena-Molina, Rishi P Verma, Marieke Heisen, Jessica Weaver, Kristen A Feemster, Thomas Weiss, Jordana Schmier
Publikováno v:
Open Forum Infectious Diseases. 9
Background As higher-valent PCVs are currently in late-stage clinical development for pediatric use, it is important to understand how healthcare providers (HCPs) evaluate vaccine attributes when making recommendations for newer PCVs. The Advisory Co
Autor:
Amer M. Zeidan, Sophie (jui-Hua) Tsai, Milad Karimi, Jordana Schmier, Sayeli Jayade, Evangelos Zormpas, Audrey Hassan, Desiree Ruiters, Cindy Anthony, Kala Hill, Tim Wert, Marc Botteman
Publikováno v:
Blood. 140:10847-10848
Autor:
Amer M. Zeidan, Jui-Hua Tsai, Milad Karimi, Jordana Schmier, Sayeli Jayade, Evangelos Zormpas, Audrey Hassan, Desiree Ruiters, Cindy Anthony, Kala Hill, Tim Wert, Marc Botteman
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(9)
Therapy with infused or injected hypomethylating agents (HMAs) may lead to higher treatment administration burden (ie, local reaction, visit frequency and duration) vs. oral HMAs. OBJECTIVES: To reveal preferences of US and Canadian patients with mye
Autor:
Vimalanand S. Prabhu, Sneha S. Kelkar, Jingchuan Zhang, Yao Qiao, Rishi P. Verma, Jordana Schmier, Nicola Miles, Jenny King, Christian Marth
Publikováno v:
Journal of Clinical Oncology. 40:e17627-e17627
e17627 Background: Until recently, recurrent or advanced endometrial cancer (aEC) patients in Europe had limited treatment options, with no consensus on standard of care in such settings. Approval of novel targeted therapies in 2021 are changing the
Autor:
Marc F. Botteman, Amer M. Zeidan, Kala Hill, Sayeli Jayade, Audrey Hassan, Jordana Schmier, Desiree Ruiters, Namita Joshi
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(3)
Background Until recently, patients with myelodysplastic syndromes (MDSs) could receive hypomethylating agents (HMAs) via intravenous (IV) or subcutaneous (SC) administration. An oral HMA was recently approved as an alternative to IV/SC administratio
Autor:
Jordana Schmierer, Toru Takimoto
Publikováno v:
Viruses, Vol 16, Iss 7, p 1136 (2024)
Influenza A viruses (IAV) utilize host proteins throughout their life cycle to infect and replicate in their hosts. We previously showed that host adaptive mutations in avian IAV PA help recruit host protein G-Rich RNA Sequence Binding Factor 1 (GRSF
Externí odkaz:
https://doaj.org/article/5affde8db518445085d199f8725f18ee